Totally endoscopic atrial septal repair in adults with computer-enhanced telemanipulation  by Wimmer-Greinecker, Gerhard et al.
Evolving
Technology
Totally endoscopic atrial septal repair in adults with
computer-enhanced telemanipulation
Gerhard Wimmer-Greinecker, MD, PhDa
Selami Dogan, MDa
Tayfun Aybek, MDa
Mohammad Fawad Khan, MDa
Stephan Mierdl, MDa
Christian Byhahn, MDb
Anton Moritz, MD, PhDa
Objective: Standard surgical closure of an atrial septal defect via sternotomy is a
safe and effective procedure with low morbidity and mortality. Considering that
young female patients are frequently operated on for atrial septal defects, a mini-
mally invasive procedure avoiding sternotomy is convincingly desirable and led to
the approach through a right anterolateral minithoracotomy. The recent clinical
introduction of robotically assisted surgery further reduced skin incisions and
enabled totally endoscopic procedures through ports. This article reports on a first
series of atrial septal defect closures of which the first case was operated on August
24, 1999, in a totally endoscopic closed chest technique using a computer-enhanced
telemanipulation system.
Methods: We performed totally endoscopic atrial septal repair using the da Vinci
surgical system (Intuitive Surgical, Mountain View, Calif) in 10 consecutive adult
patients. Median age was 45.5  10.0 years, and preoperative New York Heart
Association functional class was 1.8  0.1. Left ventricular ejection fraction was
normal in all patients and mean pulmonary artery pressure amounted to 35  7 mm
Hg. Shunt volume ranged from 24% to 70%. All patients displayed a fossa ovalis
type of atrial septal defect; 2 of them multiperforated.
Results: Neither intraoperative nor postoperative complications occurred. Two
patients had to be converted to minithoracotomy due to endoaortic balloon clamp
failure. Length of operation was 262  37 minutes, and cardiopulmonary bypass
time was 161  26 minutes. Intraoperative transesophageal echocardiography
certified complete closure of the atrial septal defect in all patients. The totally
endoscopic computer-enhanced technique yielded excellent cosmetic results.
Conclusion: Totally endoscopic atrial septal repair is a feasible and safe procedure
with good clinical results and excellent cosmetic outcomes. It may be considered as
perfect adjunct to interventional treatment options. Further studies with larger
cohorts and randomized trials are necessary to document potential benefits. Evolu-
tion in robotic technology and refinement of procedural flow may shorten procedural
time and decrease costs.
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Several methods have been described to closean atrial septal defect (ASD) in adult cardiacsurgery. The first successful ASD closure wasperformed by Lewis and Taufic1 in 1953.Since then standard surgical closure of anASD via sternotomy or thoracotomy has been
a safe and effective procedure with low morbidity and
mortality.2,3
Considering that young female patients are frequently
operated on for ASDs, a minimally invasive approach
avoiding sternotomy is convincingly desirable and led to the
development of right anterolateral minithoracotomy proce-
dures with submammary incision.4-6 Length of incision can
be reduced to 4 to 5 cm when cardiopulmonary bypass
(CPB) is instituted via femoro-femoral access using differ-
ent techniques.7-9
In parallel, closure of small ostium secundum and patent
foramen ovale types of ASD by different percutaneous
catheter techniques have been developed by interventional
cardiologists.10,11 This led to a dramatic reduction of surgi-
cally performed ASD closures.
The recent clinical introduction of robotically assisted
surgery finally enables totally endoscopic procedures
through ports. This article reports on our first series of ASD
closure in a totally endoscopic closed chest technique using
a computer-enhanced telemanipulation system.
Patients and Methods
After institutional ethical committee approval was obtained (No.
141/99 B), and each single patient gave written informed consent,
we performed totally endoscopic atrial septal repair (TEASR) in
10 consecutive adult patients with the da Vinci surgical system
(Intuitive Surgical, Mountain View, Calif).12,13. The first TEASR
was performed at Frankfurt University on August 24, 1999.14
Median age was 45.5  10.0 years, and preoperative New York
Heart Association functional class was 1.8 0.1. Two patients had
a history of paradox embolism. There were no other comorbidities.
Left ventricular ejection fraction was within the normal range in all
patients and mean pulmonary artery pressure was 35  7 mm Hg.
Shunt volume ranged from 24% to 70%.
All patients had a fossa ovalis type of ASD, multiperforated in
2 of them. Effectiveness of ASD repair was assessed intraopera-
tively and documented via transesophageal echocardiography.
Operative Technique for TEASR
Anesthesia was induced by a standard technique with a double-
lumen tube for single lung ventilation. A 19F or 21F venous
drainage cannula was inserted percutaneously into the right jugular
vein by the anesthesiologist for selective drainage of the superior
vena cava (SVC).
A right-side approach was used. The patient was placed on the
operating table with the right side of the chest elevated by 40°.
After deflation of the right lung and insufflation of the chest with
carbon dioxide, a 0° endoscope was inserted into the fourth inter-
costal space (ICS) between the midclavicular and anterior axillary
line. The robot arms were placed through the third and sixth ICS
in the anterior axillary line. After initiating CBP via femoro-
femoral cannulation with the Heartport Port-Access System (Car-
dioVations of Ethicon, Inc, Norwalk, Conn) in 8 patients or the
Estech System (Estech, Danville, Calif) in 2 patients, the pericar-
dium was incised and the SVC and inferior vena cava (IVC) were
dissected endoscopically. An additional 8-mm stab incision was
necessary in the fifth ICS in the midaxillary line for transthoracic
instrumentation. This included suction and the use of a special long
endoflex clamp (Snowden Pencer, Tucker, Ga) to circumplace
loops around the SVC and IVC, which were secured transthorac-
ically for total CPB before atrial incision. The endoaortic balloon
clamp was insufflated and cardiac arrest was achieved by delivery
of cold blood cardioplegic solution.
After incision of the right atrium, a stay suture was placed on
the atrial roof and tied to expose the defect of the interatrial
septum. The orifices of the pulmonary veins and the coronary
sinus, respectively, were verified. The defect was closed directly
with either a 4.0 polypropylene running suture or a Dacron patch
after deairing of the left side of the heart. The atriotomy was then
closed with a double running 4-0 polypropylene suture. The en-
doaortic crossclamp was desufflated and the patient was weaned
from CPB. Procedures were performed at moderate systemic hy-
pothermia (28°C).
Results
There was no perioperative morbidity. Eight of 10 patients
were treated in the described fashion. Two patients were
converted due to issues associated with Port-Access tech-
nology.15
In 1 patient stabilization of the balloon in the ascending
aorta was not possible (Heartport system). In another patient
cardioplegic delivery was obstructed, probably because of
kinking of the cardioplegia line, which is integrated in the
arterial return cannula (Estech system). In both patients a
transthoracic clamp was used for aortic occlusion,16 and the
procedure was performed through a minithoracotomy in the
fourth ICS.
In 7 patients direct ASD closure was performed with a
running suture. In 1 patient the ASD was closed with a
Dacron patch.
Intraoperative time measurements with regard to partic-
ular steps of the complex procedure are listed in Table 1,
whereby defect closure is defined as the actual time of
suturing the ASD. With intraoperative transesophageal
echocardiography, complete closure of ASD was confirmed
in all patients.
TABLE 1. Intraoperative time measurements with regard to
particular steps of the procedure
Intraoperative data Median  SD
Skin to skin time (min) 262 37
CPB (min) 161 26
Balloon clamp (min) 67 21
Defect closure (min) 19 3
Port placement (min) 10 2
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Twenty-four–hour chest tube drainage amount was 248
 89 mL, ventilation time was 11  4 hours, ICU stay was
20  33 hours, and hospital stay was 9.5  1.9 days.
The totally endoscopic approach yielded excellent cos-
metic results (Figure 1).
Discussion
Applying the standard techniques for surgical ASD closure,
midline sternotomy is still the approach of choice in many
institutions. Though this procedure yields recognized results
with low morbidity and mortality and short hospital stay,2
the nature of the technique carries the risk of wound infec-
tion,17,18 which can be the source of significant pain and is
cosmetically not desirable. Right thoracotomy is used to
avoid sternotomy, potentially decrease pain, improve cos-
mesis, and generate higher acceptance among patients. It is
reasonably debatable, though, whether pain or wound infec-
tion can be reduced, especially in young patients with no
comorbities.
With the development of Port-Access technology for
peripheral CPB induction and the use of a transthoracic
clamp, skin incision could be further reduced.8,9,16
The trade-off between longer CPB times and highly
complex procedures for the sake of improved cosmesis only
is still questionable. Associated risks with Port-Access tech-
nology such as aortic dissections and thromboembolic
events15,19,20 do not advocate for the technique, but com-
plication rate is assumed to be low in younger patient
cohorts with no peripheral vascular disease. Some authors
even discuss an increased risk of thrombus formation using
a long venous femoral cannula in the IVC,7 which we have
not experienced in our overall series of more than 200
Port-Access cases.
With the advent of telemanipulators in the late 1990s, a
new powerful tool to perform totally endoscopic cardiac
procedures has been added, enabling the surgeon to perform
coronary artery bypass grafting12,21 and valve reconstruc-
tion.22,23 However, only few reports exist that describe
robotically assisted24 or totally endoscopic ASD repair.25
The necessity for a Port-Access system that can perform
TEASR in children and patients with very small femoral
vessels is a major obstacle. Therefore, preoperative assess-
ment of femoral vessel size is required. We do recommend
dissection of femoral vessels before port placement to po-
tentially avoid additional skin incisions in case of a neces-
sary conversion. We have augmented the standard Port-
Access technique by implementing a selective percutaneous
drainage of the SVC and IVC to avoid impairment of
visualization in the right atrium by a cannula. Total CPB
was then induced by encircling both venae cavae, combin-
ing telemanipulated surgery with transthoracic instrumenta-
tion. Such a complex task requires special instruments and
a precise coordination of the patient side and the console
surgeons. Both conversions that occurred were associated
with Port-Access system failures and not with the totally
endoscopic technique itself.
Since the advances of catheter technology enabled per-
cutaneous closure of ASD, many centers have adopted this
technique and it is considered a standard approach.10,26
Secundum-type ASDs with a circumscript size and patent
foramen ovale are well suited for percutaneous catheter
closure. The success rate of the procedure is presently
described around 80%.27 Larger defects are beyond the
scope of transcatheter treatment and a surgical treatment is
required. Also, ASDs of the primum type or sinus venosus
defects are not suitable for the interventional approach.
Therefore, a totally endoscopic approach may be considered
as an adjunct to the already existing interventional treatment
options.
Complications such as intracardiac shunt recurrence,28
device dislocation, and loosening or breaking off of uphold-
ing wires have been reported.10,29 These complications may
even result in emergency operations to remove parts of the
occluder.10,26 Therefore, rigorous patient selection is neces-
sary. In addition intra-atrial prosthetic material may be a
potential source of cerebral emboli.
TEASR gives the surgeon a free hand to close most types
of ASD regardless of size, location, and shape. Only coin-
cidence with extreme types of anomalous pulmonary veins
is a contraindication since totally endoscopic snaring of
SVC and IVC may not be feasible under special anatomic
conditions.
Figure 1. A patient after TEASR.
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In this patient collective there was no intraoperative or
postoperative complication, although operative times were
prolonged as compared with standard minimally invasive
techniques. The main reason for this is the time-consuming
placement of the endoaortic balloon, where the balloon is
even more unstable in these kind of patients, who have
healthy aortas, which are much more compliant than in
patients, for example, with coronary artery disease. Echo-
cardiographic follow-up on hospital discharge revealed nor-
mal atrial septum configuration without residual shunt.
Postoperative recovery was uneventful, and patient satisfac-
tion was high with excellent cosmetic results.
In summary, our experience confirms the data reported
by Torracca and colleagues,25 who are using almost exactly
the same method. TEASR is a feasible and safe procedure
with good clinical results. Further studies with larger co-
horts and randomized trials are necessary to document po-
tential benefits. Evolution in robotic technology and refine-
ment of procedural flow may shorten procedural time and
decrease costs.
References
1. Lewis FJ, Taufic M. Closure of atrial septal defects with the aid of
hypothermia: experimental accomplishments and the report of the one
successful case. Surgery. 1953;33:52.
2. Murphy JG, Gersh BJ, McGoon MD, et al. Long-term outcome after
surgical repair of isolated atrial septal defect. Follow-up at 27 to 32
years. N Engl J Med. 1990;323:1645-50.
3. Minale C. Atrial septal defect closure through a thoracotomy. Ann
Thorac Surg. 1997;63:913-4.
4. Black MD, Freedom RM. Minimally invasive direct access for repair
of atrial septal defect in adults. Am J Cardiol. 1998;65:765-7.
5. Byrne JG, Adams DH, Mitchell ME, Cohn LH. Minimally invasive
direct access for repair of atrial septal defect in adults. Am J Cardiol.
1999;84:919-22.
6. Massetti M, Babatasi G, Rossi A, et al. Operation for atrial septal
defect through a right anterolateral thoracotomy: current outcome. Ann
Thorac Surg. 1996;62:1100-3.
7. Cremer JT, Boning A, Anssar MB, et al. Different approaches for
minimally invasive closure of atrial septal defects. Ann Thorac Surg.
1999;67:1648-52.
8. Izzat MB, Yim AP, El-Zufari MH. Limited access atrial septal defect
closure and the evolution of minimally invasive surgery. Ann Thorac
Cardiovasc Surg. 1998;4:56-8.
9. Galloway AC, Shemin RJ, Glower DD, et al. First report of the
Port-Access International Registry. Ann Thorac Surg. 1999;67:51-8.
10. Rao PS, Sideris EB, Hausdorf G, et al. International experience with
secundum atrial septal defect occlusion by the buttoned device. Am
Heart J. 1994;128:1022-35.
11. Ewert P, Berger F, Daehnert I, et al. Transcatheter closure of atrial
septal without fluoroscopy. Feasibility of new method. Circulation.
2000;101:847-9.
12. Mohr FW, Falk V, Diegeler A, Autschbach R. Computer-enhanced
coronary artery bypass surgery. J Thorac Cardiovasc Surg. 1999;117:
1212-5.
13. Dogan S, Aybek T, Andreen E, et al. Totally endoscopic coronary
artery bypass grafting on cardiopulmonary bypass with robotically
enhanced telemanipulation: report of forty-five cases. J Thorac Car-
diovasc Surg. 2002;123:1125-31.
14. Dogan S, Aybek T, Mierdl S, Westphal K, Wimmer-Greinecker G,
Moritz A. Atrial septal defect closure—first totally endoscopic intra-
cardiac procedure. Abstract guide—3rd Ann. Scientific Meeting of
Intl. Soc. for Minimally Invasive Cardiac Surgery (ISMICS), Atlanta,
Ga, June 8-10, 2000. p. 18.
15. Wimmer-Greinecker G, Matheis G, Dogan S, et al. Complications of
port-access cardiac surgery. J Card Surg. 1999;14:240-5.
16. Chitwood WR Jr, Elbeery JR, Moran JF. Minimally invasive mitral
valve repair using transthoracic aortic occlusion. Ann Thorac Surg.
1997;63:1477-9.
17. Braxton JH, Marrin CA, McGrath PD, et al. Mediastinitis and long
term survival after coronary artery bypass surgery. Ann Thorac Surg.
2000;70:2004-7.
18. Borger MA, Rao V, Wisel RD, et al. Deep sternal wound infection:
risk factors and outcomes. Ann Thorac Surg. 1998;65:1050-6.
19. Mohr FW, Falk V, Diegler A, Walther T, van Son JA, Autschbach R.
Minimally invasive port-access mitral valve surgery. J Thorac Car-
diovasc Surg. 1998;115:567-76.
20. Mohr FW, Onnach JF, Falk V, et al. The evolution of minimally
invasive valve surgery—2 year experience. Eur J Cardiothorac Surg.
1999;15:233-9.
21. Loulmet D, Carpentier A, d’Attellis N, et al. Endoscopic coronary
artery bypass grafting with the aid of robotic assisted instruments.
J Thorac Cardiovasc Surg. 1999;118:4-10.
22. Mohr FW, Falk V, Diegler A, Walther T, van Son JA, Autschbach R.
Minimally invasive Port-Access mitral valve surgery. J Thorac Car-
diovasc Surg. 1998;115:567-76.
23. Felger JE, Chitwood WR Jr, Nifong LW, Hobert D. Evolution of
mitral valve surgery: toward a totally endoscopic approach. Ann Tho-
rac Surg. 2001;72:1203-9.
24. Reichenspurner H, Boehm DH, Welz A, Schultze C, Zwissler B,
Reichart B. 3D-video and robot-assisted minimally invasive ASD
closure using the port-access technique. Heart Surg Forum. 1998;1:
104-6.
25. Torracca L, Ismeno G, Alfieri O. Totally endoscopic computer-en-
hanced atrial septal defect closure in six patients. Ann Thorac Surg.
2001;72:1254-7.
26. Rome JJ, Keane JF, Perry SB, Spevak PJ, Lock JE. Double umbrella
closure of atrial septal defects. Initial clinical application. Circulation.
1990;82:751-8.
27. Fischer G, Kramer HH, Stieh J, Harding P, Jung O. Transcatheter
closure of secundum atrial septal defects with the new self-centering
Amplatzer septal occluder. Eur Heart J. 1999;20:541-9.
28. Meijboom F, Hess J, Szatmari A, et al. Long term follow-up after
surgical closure of atrial septal defect at a young age. Am J Cardiol.
1993;72:1431-4.
29. Arabia FA, Rosado LJ, Lloyd TR, Sethi GK. Management of compli-
cations of Sideris catheter devices for atrial septal defect closure.
J Thorac Cardiovasc Surg. 1993;106:886-8.
Evolving Technology Wimmer-Greinecker et al
468 The Journal of Thoracic and Cardiovascular Surgery ● August 2003
ET
